1 Min Read
Jan 10 (Reuters) - Immune Pharmaceuticals Inc
* Immune Pharmaceuticals Inc - immune pharmaceuticals will request an appeal to regain compliance with nasdaq’s minimum bid price rule Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.